Cassava Sciences Inc

Ownership Transactions Reported by 15 Insiders

Symbol
SAVA on Nasdaq
Location
6801 N Capital Of Texas Highway, Building 1; Suite 300, Austin, TX

There are no Buy or Sell transactions made by insiders since 11/21/2023

Cassava Sciences Inc executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Sanford Robertson Director $25.2M May 16, 2024
Richard Barry President & CEO, Director $20.5M Oct 1, 2024
Eric Schoen Chief Financial Officer $2.2M Sep 6, 2024
James William Kupiec Chief Medical Officer $1.78M Sep 6, 2024
Freda Nassif Chief Commercial Officer $1.69M Nov 18, 2024
Robert Christopher Cook SVP & General Counsel $1.69M Sep 6, 2024
Jaren Landen Chief Clinical Dev. Officer $1.43M Nov 18, 2024
Remi Barbier President & CEO, Director $844K May 20, 2024
Robert Z. Gussin Director $253K May 9, 2024
Patrick J. Scannon Director $186K May 9, 2024
Pierre Gravier Director $169K May 9, 2024
Michael J. O. Donnell Director $169K May 9, 2024
Claude Nicaise Director $169K May 9, 2024
Robert Eugene Anderson Jr Director $169K May 9, 2024
Nadav Friedmann Chief Medical Officer, Director $2.5K Dec 31, 2022

Recent Insider Transactions by Companies or Individuals for Cassava Sciences Inc

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.